mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.1 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |